Elsie Biotechnologies
Blythe Dillingham is an accomplished professional in the field of biology, currently serving as the Director of Biology at Elsie Biotechnologies since September 2021, where responsibilities include overseeing the Biology Team and contributing to strategic project prioritization. Previous roles at Elsie Biotechnologies include Associate Director and Senior Scientist, where Blythe developed initial cell biology lab operations and led team expansion. Prior experience at aTyr Pharma involved advancing the tRNA synthetase discovery pipeline, while earlier research at Scripps Research focused on memory storage in neuronal networks during a PhD in Biological Sciences. Additional research roles include positions at Children's National Health System and ReveraGen BioPharma, Inc., emphasizing a strong foundation in genetic research and drug development. Blythe Dillingham holds a Bachelor of Science from the University of Maryland and a PhD from Scripps Research.
This person is not in any teams
This person is not in any offices
Elsie Biotechnologies
Elsie’s technology relies on a three dimensional platform that allows for the synthesis, deconvolution, and delivery of homogeneous oligonucleotide therapeutics. Our hope to leverage an out of the box way of thinking as well as a multidisciplinary approach to bring safer and more efficacious therapeutics to the market to treat the most intractable human diseases.